Pharmacokinetics of the Perioperative Use of Cancer Chemotherapy in Peritoneal Surface Malignancy Patients
Background. The peritoneal surface is an acknowledged locoregional failure site of abdominal malignancies. Previous treatment attempts with medical therapy alone did not result in long-term survival. During the last two decades, new treatment protocols combining cytoreductive surgery with perioperat...
Main Authors: | K. Van der Speeten, K. Govaerts, O. A. Stuart, P. H. Sugarbaker |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2012-01-01
|
Series: | Gastroenterology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2012/378064 |
Similar Items
-
A Pharmacokinetic and Pharmacodynamic Rationale for Perioperative Cancer Chemotherapy in Patients with Peritoneal Carcinomatosis
by: Van der Speeten, Kurt
Published: (2010) -
Perioperative intraperitoneal chemotherapy for peritoneal surface malignancy
by: Yoo Dal, et al.
Published: (2006-04-01) -
Pharmacokinetic Study of Perioperative Intravenous Ifosfamide
by: Kurt Van der Speeten, et al.
Published: (2011-01-01) -
Gastrointestinal Complications in 147 Consecutive Patients with Peritoneal Surface Malignancy Treated by Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy
by: Angela Casado-Adam, et al.
Published: (2011-01-01) -
Cytoreductive Surgery Plus Hyperthermic Perioperative Chemotherapy for Selected Patients with Peritoneal Metastases from Colorectal Cancer: A New Standard of Care or an Experimental Approach?
by: Paul H. Sugarbaker
Published: (2012-01-01)